<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Carl Zeiss Meditec Ag — News on 6ix</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag</link>
<description>Latest news and press releases for Carl Zeiss Meditec Ag on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 23 Feb 2026 14:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/carl-zeiss-meditec-ag" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836008b78dffbe2df133e31.webp</url>
<title>Carl Zeiss Meditec Ag</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag</link>
</image>
<item>
<title>ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-launches-collaborative-care-application-to-strengthen-continuity-of-care-new-solution-offers-on-premises-and-cloud-based-options</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-launches-collaborative-care-application-to-strengthen-continuity-of-care-new-solution-offers-on-premises-and-cloud-based-options</guid>
<pubDate>Mon, 23 Feb 2026 14:00:00 GMT</pubDate>
<description>ZEISS Medical Technology, one of the world's leading medical technology companies, today launched its ZEISS Collaborative Care browser-based software application enabling eye care professionals to seamlessly work together securely sharing data, referring patients, and strengthening their professional networks. The new solution addresses longstanding challenges in ophthalmic care, particularly fragmented data sharing, and inefficient referral processes. By enabling real-time communication, struct</description>
</item>
<item>
<title>ZEISS announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-announces-nmpa-approval-in-china-for-powerful-ophthalmic-microscopes-enhancing-surgical-visualization</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-announces-nmpa-approval-in-china-for-powerful-ophthalmic-microscopes-enhancing-surgical-visualization</guid>
<pubDate>Mon, 02 Feb 2026 23:00:00 GMT</pubDate>
<description>ZEISS Medical Technology announced today that China's National Medical Products Administration (NMPA) has approved the ZEISS ARTEVO 750 and ARTEVO 850 ophthalmic microscopes. The microscopes provide high quality optical and digital visualization for both anterior and posterior segments. With upgrades spanning both hardware and software, the newly approved microscopes supporting ophthalmic surgeries ensure more precise operations and greater surgical safety with enhanced resolution, RGB illuminat</description>
</item>
<item>
<title>FluoGuide Signs Collaboration Agreement with ZEISS</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/fluoguide-signs-collaboration-agreement-with-zeiss-2</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/fluoguide-signs-collaboration-agreement-with-zeiss-2</guid>
<pubDate>Tue, 25 Nov 2025 14:15:00 GMT</pubDate>
<description>KØBENHAVN, DK / ACCESS Newswire / November 25, 2025 / FluoGuide A/S (STO:FLUO) - Copenhagen, Denmark, 25 November 2025 - FluoGuide A/S, a biotech company specializing in precision cancer surgery, announces a signed collaboration agreement with ZEISS ...</description>
</item>
<item>
<title>ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-expands-dorc-portfolio-and-further-strengthens-digital-footprint-with-improved-workflow-efficiency-and-digital-visualization</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-expands-dorc-portfolio-and-further-strengthens-digital-footprint-with-improved-workflow-efficiency-and-digital-visualization</guid>
<pubDate>Tue, 07 Oct 2025 13:00:00 GMT</pubDate>
<description>ZEISS Medical Technology will showcase its latest enhancements in ophthalmic visualization and digital workflow innovation at the American Academy of Ophthalmology (AAO) conference from Oct. 18 - 20, 2025, in Orlando, FL.</description>
</item>
<item>
<title>Nokia expands defense portfolio with two advanced tactical communication solutions</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/nokia-expands-defense-portfolio-with-two-advanced-tactical-communication-solutions-209</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/nokia-expands-defense-portfolio-with-two-advanced-tactical-communication-solutions-209</guid>
<pubDate>Tue, 09 Sep 2025 07:00:00 GMT</pubDate>
<description>Nokia Mission-Safe Phone Nokia Mission-Safe Phone Nokia Banshee 5G Tactical Radio Nokia Banshee 5G Tactical Radio Press Release Nokia expands defense portfolio with two advanced tactical communication solutions Introduces Nokia Mission-Safe Phone, a purpose-built defense smartphone for reliable mission-critical communications in the harshest operational environmentsNokia also launches the upgraded Banshee 5G Tactical Radio, a rugged, portable, easy-to-deploy network hub, now with integrated 5G c</description>
</item>
<item>
<title>ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-showcases-expansion-of-ophthalmic-care-options-creating-industry-leading-workflow-solutions-marks-new-refractive-and-cataract-milestones</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-showcases-expansion-of-ophthalmic-care-options-creating-industry-leading-workflow-solutions-marks-new-refractive-and-cataract-milestones</guid>
<pubDate>Tue, 02 Sep 2025 12:00:00 GMT</pubDate>
<description>ZEISS Medical Technology showcases the latest innovations and enhancements to its cataract and corneal refractive workflow solutions, from diagnostics and surgical planning to advanced treatments, at the European Society of Cataract and Refractive Surgeons (ESCRS) conference in Copenhagen, Denmark, from Sept. 12-15, 2025.</description>
</item>
<item>
<title>ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-showcases-comprehensive-workflow-for-full-spectrum-of-retina-care-at-euretina</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-showcases-comprehensive-workflow-for-full-spectrum-of-retina-care-at-euretina</guid>
<pubDate>Tue, 26 Aug 2025 12:00:00 GMT</pubDate>
<description>ZEISS Medical Technology will showcase its most advanced and comprehensive retina portfolio yet -- spanning from pathology detection and assessment to planning and treatment -- at the European Society of Retina Specialists (EURETINA) conference in Paris, France, from Sept. 4 – 7, 2025. ZEISS is one of very few companies offering the full spectrum of retinal care, combining diagnostic imaging, digital workflow tools and vitreoretinal surgical technologies, to support data continuity, procedural e</description>
</item>
<item>
<title>ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-announces-ce-mark-for-cirrus-pathfinder-ai-tool-with-automated-oct-assessment</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-announces-ce-mark-for-cirrus-pathfinder-ai-tool-with-automated-oct-assessment</guid>
<pubDate>Thu, 21 Aug 2025 12:00:00 GMT</pubDate>
<description>ZEISS Medical Technology today announced CE mark approval for CIRRUS® PathFinder™, an innovative clinical support tool with artificial intelligence (AI) fully integrated to enable more confident decision-making and accelerate a clinician's workflow with OCT interpretation assistance. ZEISS CIRRUS PathFinder1 uses proprietary deep learning algorithms to automatically identify abnormal macular OCT B-scans as a licensed element of a new CIRRUS software release, that also provides AI-enhanced OCTA i</description>
</item>
<item>
<title>Kopin and HMDmd Commence Production Deliveries of Wearable Surgical Display Systems to Carl Zeiss Meditec</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/kopin-and-hmdmd-commence-production-deliveries-of-wearable-surgical-display-systems-to-carl-zeiss-meditec</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/kopin-and-hmdmd-commence-production-deliveries-of-wearable-surgical-display-systems-to-carl-zeiss-meditec</guid>
<pubDate>Tue, 22 Jul 2025 12:27:00 GMT</pubDate>
<description>WESTBOROUGH, Mass., July 22, 2025--Kopin Corporation (NASDAQ: KOPN) a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, has announced, in collaboration with HMDmd, the first production delivery of the CR3 wearable surgical monitor (purpose-built for surgery) to Carl Zeiss Meditec, a top-tier global medical technology company.</description>
</item>
<item>
<title>ZEISS Group Appoints Martin Fischer as President and CEO of ZEISS Greater China</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-group-appoints-martin-fischer-as-president-and-ceo-of-zeiss-greater-china</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-group-appoints-martin-fischer-as-president-and-ceo-of-zeiss-greater-china</guid>
<pubDate>Thu, 17 Jul 2025 02:00:00 GMT</pubDate>
<description>ZEISS Group recently announced that Martin Fischer will officially take on the role of President and CEO of ZEISS Greater China, effective from October 1, 2025, reporting directly to Andreas Pecher, President and CEO of the ZEISS Group. Martin Fischer succeeds Maximilian Foerst, who joined the Executive Board of the ZEISS Group as the President and CEO of Carl Zeiss Meditec AG on June 1, 2025. ZEISS Greater China manages all business activities in China's mainland, Hong Kong SAR, and Taiwan Regi</description>
</item>
<item>
<title>ZEISS CLARUS 700 Receives NMPA Approval in China</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-clarus-700-receives-nmpa-approval-in-china</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-clarus-700-receives-nmpa-approval-in-china</guid>
<pubDate>Thu, 05 Jun 2025 22:00:00 GMT</pubDate>
<description>ZEISS Medical Technology announced today that the CLARUS® 700 from ZEISS has received National Medical Products Administration (NMPA) approval in China, offering advanced retinal diagnostic capabilities with ultra-widefield, high-resolution images in True Color and unsurpassed quality. The fundus imaging device with Fluorescein Angiography helps eye care specialists in China unlock the full potential of their clinic's retina workflow to support improved patient vision preservation.</description>
</item>
<item>
<title>ZEISS unveils AI-powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-unveils-ai-powered-research-data-platform-collaboration-with-boehringer-ingelheim-champions-the-future-of-personalized-eye-care</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-unveils-ai-powered-research-data-platform-collaboration-with-boehringer-ingelheim-champions-the-future-of-personalized-eye-care</guid>
<pubDate>Wed, 30 Apr 2025 13:00:00 GMT</pubDate>
<description>ZEISS demonstrates a new standard for the future of ophthalmic research at the Association for Research in Vision and Ophthalmology (ARVO) conference, from May 4 – 8, including the introduction of the new ZEISS Research Data Platform (ZEISS RDP), and a spotlight on the ongoing research collaboration with Boehringer Ingelheim to accelerate personalized, data-driven treatment approaches in ophthalmology.</description>
</item>
<item>
<title>ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-planned cataract cases in the U.S. alone</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-continues-to-drive-digital-era-forward-in-ophthalmology-celebrates-2-million-digitally-planned-cataract-cases-in-the-us-alone</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-continues-to-drive-digital-era-forward-in-ophthalmology-celebrates-2-million-digitally-planned-cataract-cases-in-the-us-alone</guid>
<pubDate>Thu, 17 Apr 2025 13:00:00 GMT</pubDate>
<description>ZEISS Medical Technology will celebrate the rapid adoption of digital cataract solutions and showcase newly available refractive treatment technology at the American Society of Cataract and Refractive Surgery (ASCRS) conference from April 25 – 27 in Los Angeles, CA. ZEISS marks a major milestone in the U.S. with more than 2 million digitally planned cases using the ZEISS VERACITY Surgery Planner,1 one of the leading digital planning solutions for cataract surgery, which serves as a testament to</description>
</item>
<item>
<title>ZEISS receives FDA clearance for INTRABEAM 700</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-receives-fda-clearance-for-intrabeam-700</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-receives-fda-clearance-for-intrabeam-700</guid>
<pubDate>Wed, 09 Apr 2025 11:11:00 GMT</pubDate>
<description>As a leading provider of medical solutions in the field of neurosurgery, ZEISS Medical Technology is also dedicated to shaping modern oncology. The company recently received 510(k) clearance from the US Food and Drug Administration (FDA) for INTRABEAM® 700 – a leading-edge platform that provides robotic-assisted precision to support intraoperative radiation therapy (IORT). With its modern digital-first architecture, ZEISS INTRABEAM 700 creates SMART workflow efficiency and provides seamless conn</description>
</item>
<item>
<title>ZEISS Introduces VISULAS Combi in Canada; a Revolutionary Therapeutic Laser Workstation for Enhanced Eye Care</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-introduces-visulas-combi-in-canada-a-revolutionary-therapeutic-laser-workstation-for-enhanced-eye-care</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-introduces-visulas-combi-in-canada-a-revolutionary-therapeutic-laser-workstation-for-enhanced-eye-care</guid>
<pubDate>Fri, 21 Mar 2025 14:00:00 GMT</pubDate>
<description>ZEISS Medical Technology announced today the availability in Canada of the ZEISS VISULAS Combi, an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp technology in a single, comprehensive solution. Designed for the treatment of retina, cataract, and glaucoma conditions, the ZEISS VISULAS Combi streamlines workflows with customizable modules, a uniform interface, and space-saving features. It enables seamless eye care without the need for time-consumi</description>
</item>
<item>
<title>ZEISS VISUMAX 800 with SMILE pro software receives approval in China</title>
<link>https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-visumax-800-with-smile-pro-software-receives-approval-in-china</link>
<guid isPermaLink="true">https://6ix.com/company/carl-zeiss-meditec-ag/news/zeiss-visumax-800-with-smile-pro-software-receives-approval-in-china</guid>
<pubDate>Wed, 26 Feb 2025 23:00:00 GMT</pubDate>
<description>ZEISS Medical Technology announced today that the National Medical Products Administration (NMPA) in China has approved the VISUMAX® 800 with SMILE® pro software from ZEISS for surgically treating nearsightedness, with or without astigmatism. The latest generation of femtosecond lasers from ZEISS enters the China market at a time when more than 10 million eyes have been treated with ZEISS SMILE and SMILE pro worldwide, reflecting the technology's broad global momentum driven by strong adoption i</description>
</item>
</channel>
</rss>